These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30997931)

  • 1. The Influence of Proinflammatory Cytokines on Voriconazole Trough Concentration in Patients With Different Forms of Hematologic Disorders.
    Mafuru M; Wu S; He S; Lu X; Huang J; Jiang H
    J Clin Pharmacol; 2019 Oct; 59(10):1340-1350. PubMed ID: 30997931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of procalcitonin with voriconazole concentrations: a retrospective cohort study.
    Zhou JX; Xiong CL; Chang ZS; Yin YC; Su KP; Zhang JH; Wu JC; Sun B
    BMC Infect Dis; 2024 Sep; 24(1):952. PubMed ID: 39256640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of voriconazole concentrations in patients with hematopoietic stem cell transplantation and hematological malignancies: influence of loading dose, procalcitonin, and pregnane X receptor polymorphisms.
    Zeng G; Wang L; Shi L; Li H; Zhu M; Luo J; Zhang Z
    Eur J Clin Pharmacol; 2020 Apr; 76(4):515-523. PubMed ID: 31932875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability of voriconazole plasma concentrations after allogeneic hematopoietic stem cell transplantation: impact of cytochrome p450 polymorphisms and comedications on initial and subsequent trough levels.
    Gautier-Veyret E; Fonrose X; Tonini J; Thiebaut-Bertrand A; Bartoli M; Quesada JL; Bulabois CE; Cahn JY; Stanke-Labesque F
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2305-14. PubMed ID: 25645831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Analysis of the Effect of Inflammation on Voriconazole Trough Concentrations.
    Encalada Ventura MA; van Wanrooy MJ; Span LF; Rodgers MG; van den Heuvel ER; Uges DR; van der Werf TS; Kosterink JG; Alffenaar JW
    Antimicrob Agents Chemother; 2016 May; 60(5):2727-31. PubMed ID: 26883707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderate correlation between systemic IL-6 responses and CRP with trough concentrations of voriconazole.
    Vreugdenhil B; van der Velden WJFM; Feuth T; Kox M; Pickkers P; van de Veerdonk FL; Blijlevens NMA; Brüggemann RJM
    Br J Clin Pharmacol; 2018 Sep; 84(9):1980-1988. PubMed ID: 29744898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Plasma Trough Concentration of Voriconazole and Voriconazole N-Oxide in Its Hepatotoxicity in Adult Patients.
    Cheng L; You X; Wang X; Yu M; Jia C
    Drug Des Devel Ther; 2024; 18():3617-3628. PubMed ID: 39156484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers.
    Cojutti P; Candoni A; Forghieri F; Isola M; Zannier ME; Bigliardi S; Luppi M; Fanin R; Pea F
    Basic Clin Pharmacol Toxicol; 2016 Jun; 118(6):474-9. PubMed ID: 26572687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of CYP2C19 genotype with plasma voriconazole exposure in South-western Chinese Han patients with invasive fungal infections.
    Miao Q; Tang JT; van Gelder T; Li YM; Bai YJ; Zou YG; Wang LL; Shi YY
    Medicine (Baltimore); 2019 Jan; 98(3):e14137. PubMed ID: 30653146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Combined Effect of CYP2C19 Genetic Polymorphism and Proton Pump Inhibitors Coadministration on Trough Concentration of Voriconazole.
    Mafuru M; Wu S; Mayala H; Msengwa Z; Phillip A; Mgone C
    Pharmgenomics Pers Med; 2021; 14():1379-1389. PubMed ID: 34754219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Drug Monitoring of Voriconazole in Patients with End-Stage Liver Disease.
    Wu Z; Jiang M; Yan M; Li G; Zeng Z; Zhang X; Li N; Jiang Y; Gong G; Zhang M
    Ther Drug Monit; 2024 Feb; 46(1):89-94. PubMed ID: 38192036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical Analysis of Voriconazole Concentrations in Cerebrospinal Fluid and Blood in Patients with Ryptococcal Meningitis].
    Xiao GR; Liu ZZ; Tang GM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):192-197. PubMed ID: 36647666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voriconazole therapeutic drug monitoring including analysis of CYP2C19 phenotype in immunocompromised pediatric patients with invasive fungal infections.
    Resztak M; Zalewska P; Wachowiak J; Sobkowiak-Sobierajska A; Główka FK
    Eur J Clin Pharmacol; 2024 Nov; 80(11):1829-1840. PubMed ID: 39240338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole concentration is inversely correlated with corticosteroid usage in immunocompromised patients.
    Imataki O; Yamaguchi K; Uemura M; Fukuoka N
    Transpl Infect Dis; 2018 Aug; 20(4):e12886. PubMed ID: 29570914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors Influencing and Adverse Reactions of Voriconazole Clearance in Patients with Hematological Diseases].
    Huang HG; Wang HL; Lin YK; Yi YD; Liu M; Dong JL; Liu JM; Chen F; Deng TY; Hu S
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):562-567. PubMed ID: 37096534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation Affects Liver Function and the Metabolism of Voriconazole to Voriconazole-N-Oxide in Adult and Elderly Patients.
    Liang Z; Yu M; Liu Z; Liu F; Jia C; Xiong L; Dai Q; Qin S; Cheng L; Sun F
    Front Pharmacol; 2022; 13():835871. PubMed ID: 35462904
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of Obesity on Voriconazole Pharmacokinetics among Pediatric Hematopoietic Cell Transplant Recipients.
    Takahashi T; Smith AR; Jacobson PA; Fisher J; Rubin NT; Kirstein MN
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32988816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration?
    Girmenia C; Annino L; Bertaina A; Mariotti B; Caselli D; Fanci R; Barberi W; Marchesi F; Carotti A; Ferrari A; Cerchiara E; Cupelli L; Arcioni F; Ribersani M; Proia A; Cartoni C; Girardi K; Venditti A; Cassetta MI; Fallani S; Novelli A
    Med Mycol; 2018 Apr; 56(3):263-278. PubMed ID: 28992093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of CYP2C19 Phenotype and Drug-Drug Interactions on Voriconazole Concentration in Pediatric Patients.
    Tian X; Zhang C; Qin Z; Wang D; Yang J; Zhang X
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0020721. PubMed ID: 34152823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood concentration was markedly elevated after administration of azole antifungal agents.
    Fujita Y; Araki T; Okada Y; Aomori T; Shimizu R; Tomizawa T; Hiromura K; Nojima Y; Nakamura T; Yamamoto K
    J Clin Pharm Ther; 2013 Feb; 38(1):74-6. PubMed ID: 22971159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.